Recent News

• 09.03.2025 - Citi's 2025 Biopharma Back to School Conference
• 08.26.2025 - Cogent Biosciences Announces Participation in the Citi Biopharma Conference
• 08.05.2025 - Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results
• 07.10.2025 - Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
• 07.09.2025 - Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
• 07.08.2025 - Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock

Recent Filings

• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - 8-K Current report
• 08.05.2025 - EX-99.1 EX-99.1
• 07.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.14.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 07.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors